They've had significant fluctuations in profitability in the past few years:
NPAT
2019: $13m
2020: $16m
2021: $47m
2022: $41m
Not sure how much they were a lockdown beneficiary given that seeming correlation and without guidance it's hard to forecast 2023.
But at trailing 7x NPAT with a 14% gross dividend if they can match something like $40m NPAT consistantly it doesn't need to grow earnings to beat the market.
Blundy invested is huge for confidence and a major factor in believing this could be an investment with future excess returns.
- Forums
- ASX - By Stock
- BST
- Ann: FY22 Full Year Results Presentation
BST
best & less group holdings ltd
Add to My Watchlist
0.00%
!
$1.88

Ann: FY22 Full Year Results Presentation, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.88 |
Change
0.000(0.00%) |
Mkt cap ! $235.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BST (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online